Search results (1376)
« Back to PublicationsA review of the statistical analysis of randomised controlled trials conducted within OCTRU.
Ooms A. et al, (2025), Trials, 26
The burden of hand trauma surgery on primary care in the United Kingdom: a nation-wide analysis of antibiotic and opioid prescriptions.
Wormald JC. et al, (2025), J hand surg eur vol
Improving the completeness and transparency of protocols and reports of randomized trials: SPIRIT 2025 and CONSORT 2025.
Moher D. et al, (2025), J clin epidemiol
CONSORT 2025 statement: updated guideline for reporting randomised trials.
Hopewell S. et al, (2025), Lancet
The impact of complications on quality of life and mortality after hip fracture
Goh EL. et al, (2025), Bone and joint journal
The World Hip Trauma Evaluation (WHiTE) platform trial: a framework for randomized comparisons of interventions for fragility hip fracture.
Costa ML. et al, (2025), Bone jt open, 6, 383 - 390
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial.
Cook JA. et al, (2025), Lancet haematol, 12, e294 - e303
Describing the landscape of nutrition- and diet-related randomized controlled trials: metaresearch study of protocols published between 2012 and 2022.
Silva FM. et al, (2025), Am j clin nutr, 121, 882 - 891
Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT
Abhishek A. et al, (2025), Efficacy and mechanism evaluation, 1 - 42
Prevalence of complications in older adults after hip fracture surgery: a systematic review and meta-analysis
Goh E. et al, (2025), Bone and joint journal, 107-B, 139 - 148
Developing generic clinical trial animated explainer videos in the UK: results of a survey and case study.
Calvert C. et al, (2025), Trials, 26
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials.
Rekowski J. et al, (2025), Eclinicalmedicine, 79
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols.
Ursino M. et al, (2025), Eclinicalmedicine, 79